Comparison of three alternatives for the management of moderate asthma in children aged 6–11 years: a cost-utility analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma"
DOI: 10.1080/02770903.2022.2093221
Abstract: Abstract Background Recent asthma guidelines for children 6–11 years with persistent asthma advocate three alternatives: SMART (budesonide/formoterol 80/4.5 mcg qd plus additional doses as needed), fixed combination of budesonide/formoterol, and fixed-dose budesonide. Concerns have arisen as to… read more here.
Keywords: dose budesonide; fixed dose; asthma; combination fixed ... See more keywords